5 Key Takeaways

• 1

  Dropless cataract surgery aims to improve reliability by administering treatment at the time of surgery, reducing patient adherence issues.

• 2

  The technique involves using intracameral antibiotics and a subconjunctival depot of triamcinolone to manage postoperative inflammation.

• 3

  Evidence supports the effectiveness of subconjunctival triamcinolone, showing comparable outcomes to traditional topical steroid regimens.

• 4

  Patient selection is crucial; dropless surgery is ideal for those with poor dexterity or compliance but may not suit patients with certain ocular conditions.

• 5

  Dropless surgery enhances postoperative care by minimizing reliance on patient-administered drops, thus improving consistency and outcomes.